PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [A3-D0]
Usd: 350 Special Discount
Specification
Catalog# M1510-2
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [A3-D0]
-
WB
-
IF-Cell
-
Human
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_M1510-2_Europe.pdf
- No MSDS Found
Overview
Product Name
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [A3-D0]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Recombinant protein within Human PI3-kinase p85 subunit alpha aa 19-219 / 724.
Species Reactivity
Human
Validated Applications
WB, IF-Cell
Target Molecular Weight
Predicted band size: 84 kDa
Positive Control
SW480 cell lysate, A431 cell lysate, 293T cell lysate, Jurkat cell lysate, A549 cell lysate.
Conjugation
unconjugated
Clone Number
A3-D0
RRID
Reactivity Data
Verified (internally validated)
Reported in literature (not internally validated)
Predicted reactive (based on sequence homology)
Not recommended (failed internal validation)
| WB | IHC-P | FC | IF-Cell | |
|---|---|---|---|---|
| human |
|
|
|
|
| mouse |
|
|
|
|
| rat |
|
|
|
|
Product Features
Form
Liquid
Concentration
2 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000-1:2,000
-
IF-Cell
-
1:50-1:200
Target
Function
Phosphatidylinositol 3-kinase (PI 3-kinase) is composed of (p85) and (p110) subunits. p85 lacks PI 3-kinase activity and acts as an adapter, coupling p110 to activated protein tyrosine kinase. Two forms of p85 have been described (p85α and p85β), each possessing one SH3 and two SH2 domains. Various p110 isoforms have been identified. p110α and p110β interact with p85α, and p110α has also been shown to interact with p85β in vitro. p110δ expression is restricted to white blood cells. It has been shown to bind p85α and γ, but it apparently does not phosphorylate these subunits. p110δ seems to have the capacity to autophosphorylate. p110γ does not interact with the p85 subunits. It has been shown to be activated by α and βγ heterotrimeric G proteins.
Background References
1. Hu J et al. Filamin B regulates chondrocyte proliferation and differentiation through Cdk1 signaling. PLoS One 9:e89352 (2014).
2. Schmidt JW et al. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis. Mol Cell Biol 34:1363-77 (2014).
Sequence Similarity
Belongs to the PI3K p85 subunit family.
Tissue Specificity
Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).
Post-translational Modification
Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.; Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear (By similarity). Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.
Subcellular Location
Cytosol, Membrane, Nucleus.
UNIPROT
Synonyms
GRB1 antibody
p85 alpha antibody
p85 antibody
P85A_HUMAN antibody
Phosphatidylinositol 3 kinase associated p 85 alpha antibody
Phosphatidylinositol 3 kinase regulatory 1 antibody
Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 1 (p85 alpha) antibody
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha antibody
Phosphatidylinositol 3-kinase regulatory subunit alpha antibody
Phosphoinositide 3 kinase, regulatory subunit 1 (alpha) antibody
ExpandGRB1 antibody
p85 alpha antibody
p85 antibody
P85A_HUMAN antibody
Phosphatidylinositol 3 kinase associated p 85 alpha antibody
Phosphatidylinositol 3 kinase regulatory 1 antibody
Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 1 (p85 alpha) antibody
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha antibody
Phosphatidylinositol 3-kinase regulatory subunit alpha antibody
Phosphoinositide 3 kinase, regulatory subunit 1 (alpha) antibody
PI3 kinase p85 subunit alpha antibody
PI3-kinase regulatory subunit alpha antibody
PI3-kinase subunit p85-alpha antibody
PI3K antibody
PI3K regulatory subunit alpha antibody
Pik3r1 antibody
PtdIns 3 kinase p85 alpha antibody
PtdIns-3-kinase regulatory subunit alpha antibody
PtdIns-3-kinase regulatory subunit p85-alpha antibody
CollapseImages
-
Western blot analysis of PI 3 Kinase p85 alpha on different lysates with Mouse anti-PI 3 Kinase p85 alpha antibody (M1510-2) at 1/1,000 dilution.
Lane 1: SW480 cell lysate
Lane 2: A431 cell lysate
Lane 3: 293T cell lysate
Lane 4: Jurkat cell lysate
Lane 5: A549 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 84 kDa
Observed band size: 84 kDa
Exposure time: 1 minute 20 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (M1510-2) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of PI 3 Kinase p85 alpha on different lysates with Mouse anti-PI 3 Kinase p85 alpha antibody (M1510-2) at 1/2,000 dilution.
Lane 1: A549-si NT cell lysate
Lane 2: A549-si PI 3 Kinase p85 alpha cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 84 kDa
Observed band size: 84 kDa
Exposure time: 2 minutes; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (M1510-2) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of U-937 cells labeling PI 3 Kinase p85 alpha with Mouse anti-PI 3 Kinase p85 alpha antibody (M1510-2) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-PI 3 Kinase p85 alpha antibody (M1510-2) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) were used as the secondary antibody at 1/1,000 dilution.
Citation
-
Mechanistic Insights Into the Hepatoprotective Effects of Punicalagin Against Oxidative Stress: Involvement of the PI3K/AKT/mTOR Pathway and Autophagy
Journal: Journal Of Food Biochemistry
DOI: 10.1155/jfbc/1703966
IF: 2.3
Application: WB
Reactivity: Human
Publish date: 2026 May
-
PIK3R1 as a Gastric Cancer Biomarker Linked to CD73+ Treg-Mediated Immunosuppression
Journal: Oncology Research
DOI: 10.32604/or.2025.069453
IF: 4.1
Application: IHC
Reactivity: Human
Publish date: 2026 Jan
-
Omentin-1 promotes diabetic wound healing by regulating macrophage efferocytosis and M2 polarization
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2026.150757
IF: 8.5
Application: WB
Reactivity: Human,Mouse
Publish date: 2026 Feb
-
Conjugating 10,11-Dimethoxy-camptothecin with an Integrin αvβ3-Targeting Peptide through a Triazine Linker for Targeted Tumor Treatment in Lung and Pancreatic Carcinoma
Journal: Journal Of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.5c02059
IF: 6.8
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Exosomal SPRY4 from adipogenic BMSCs impairs angiogenesis via the PTPRB/TIE2/PI3K axis in Steroid-induced osteonecrosis of the femoral head
Journal: Stem Cell Research & Therapy
DOI: 10.1186/s13287-025-04505-0
IF: 7.3
Application: WB
Reactivity: Human
Publish date: 2025 Jul
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Alternative Products
PI 3 Kinase p85 alpha Recombinant Rabbit Monoclonal Antibody [SU04-07]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PI 3 Kinase p85 alpha Recombinant Rabbit Monoclonal Antibody [JE04-11]
Application: WB
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PI 3 Kinase p85 alpha Recombinant Mouse Monoclonal Antibody [A3-D0-R]
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
Products with the same target and pathway
PI 3 Kinase p85 alpha Recombinant Rabbit Monoclonal Antibody [SU04-07]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [L3-D6]
Application: WB,IHC-P,IF-Cell,IF-Tissue
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PI 3 Kinase p85 alpha Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated